Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
95.36
-3.76 (-3.79%)
Apr 6, 2026, 4:00 PM EDT - Market closed
Revolution Medicines Analyst Ratings
Total Analysts
17
Consensus Rating
Strong Buy
Price Target
$120.47
Upside
+26.33%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $88 → $140 | Strong Buy | Initiates | $88 → $140 | +46.81% | Mar 16, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $75 → $120 | Buy | Maintains | $75 → $120 | +25.84% | Feb 26, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $100 → $144 | Buy | Maintains | $100 → $144 | +51.01% | Feb 26, 2026 |
| Needham | Needham | Strong Buy Maintains $150 → $145 | Strong Buy | Maintains | $150 → $145 | +52.06% | Feb 26, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $92 → $122 | Buy | Maintains | $92 → $122 | +27.94% | Feb 2, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $75 → $150 | Buy | Maintains | $75 → $150 | +57.30% | Jan 27, 2026 |
| Stifel | Stifel | Strong Buy Maintains $85 → $170 | Strong Buy | Maintains | $85 → $170 | +78.27% | Jan 22, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $77 → $140 | Buy | Maintains | $77 → $140 | +46.81% | Jan 21, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $92 → $160 | Strong Buy | Maintains | $92 → $160 | +67.79% | Jan 20, 2026 |
| Mizuho | Mizuho | Buy Maintains $90 → $143 | Buy | Maintains | $90 → $143 | +49.96% | Jan 13, 2026 |
| Wedbush | Wedbush | Buy Maintains $80 → $147 | Buy | Maintains | $80 → $147 | +54.15% | Jan 9, 2026 |
| Wolfe Research | Wolfe Research | Buy Initiates $75 | Buy | Initiates | $75 | -21.35% | Nov 18, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $71 → $82 | Buy | Maintains | $71 → $82 | -14.01% | Nov 6, 2025 |
| Wedbush | Wedbush | Buy Maintains $77 → $80 | Buy | Maintains | $77 → $80 | -16.11% | Nov 6, 2025 |
| Needham | Needham | Strong Buy Maintains $66 → $72 | Strong Buy | Maintains | $66 → $72 | -24.50% | Nov 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $72 → $73 | Strong Buy | Maintains | $72 → $73 | -23.45% | Nov 6, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.